156 related articles for article (PubMed ID: 21426665)
1. [DNA methylation of tumor suppressor genes located on chromosome 3p in non-small cell lung cancer].
Song H; Yi J; Zhang Y; Wang R; Chen L
Zhongguo Fei Ai Za Zhi; 2011 Mar; 14(3):233-8. PubMed ID: 21426665
[TBL] [Abstract][Full Text] [Related]
2. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
Zhang Y; Miao Y; Yi J; Wang R; Chen L
Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
[TBL] [Abstract][Full Text] [Related]
3. Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer.
Zhang Y; Wang R; Song H; Huang G; Yi J; Zheng Y; Wang J; Chen L
Cancer Lett; 2011 Apr; 303(1):21-8. PubMed ID: 21255913
[TBL] [Abstract][Full Text] [Related]
4. CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer.
Liu Z; Zhao J; Chen XF; Li W; Liu R; Lei Z; Liu X; Peng X; Xu K; Chen J; Liu H; Zhou QH; Zhang HT
Lung Cancer; 2008 Oct; 62(1):15-22. PubMed ID: 18358560
[TBL] [Abstract][Full Text] [Related]
5. DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma.
Seng TJ; Currey N; Cooper WA; Lee CS; Chan C; Horvath L; Sutherland RL; Kennedy C; McCaughan B; Kohonen-Corish MR
Br J Cancer; 2008 Jul; 99(2):375-82. PubMed ID: 18594535
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients.
Pastuszak-Lewandoska D; Kordiak J; Migdalska-Sęk M; Czarnecka KH; Antczak A; Górski P; Nawrot E; Kiszałkiewicz JM; Domańska D; Brzeziańska-Lasota E
Respir Res; 2015 Jun; 16(1):76. PubMed ID: 26112163
[TBL] [Abstract][Full Text] [Related]
7. Expression level and methylation status of three tumor suppressor genes, DLEC1, ITGA9 and MLH1, in non-small cell lung cancer.
Pastuszak-Lewandoska D; Kordiak J; Antczak A; Migdalska-Sęk M; Czarnecka KH; Górski P; Nawrot E; Kiszałkiewicz JM; Domańska-Senderowska D; Brzeziańska-Lasota E
Med Oncol; 2016 Jul; 33(7):75. PubMed ID: 27287342
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance of aberrant methylation of RARbeta2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancer.
Tomizawa Y; Iijima H; Nomoto T; Iwasaki Y; Otani Y; Tsuchiya S; Saito R; Dobashi K; Nakajima T; Mori M
Lung Cancer; 2004 Dec; 46(3):305-12. PubMed ID: 15541815
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer.
Kim H; Kwon YM; Kim JS; Lee H; Park JH; Shim YM; Han J; Park J; Kim DH
J Clin Oncol; 2004 Jun; 22(12):2363-70. PubMed ID: 15197197
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
[TBL] [Abstract][Full Text] [Related]
11. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.
Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
Cancer Res; 2003 Jul; 63(13):3724-8. PubMed ID: 12839965
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas.
Wang Z; Li L; Su X; Gao Z; Srivastava G; Murray PG; Ambinder R; Tao Q
J Transl Med; 2012 Oct; 10():209. PubMed ID: 23050586
[TBL] [Abstract][Full Text] [Related]
13. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic value of methylation status of RASSF1A gene as an independent factor of non-small cell lung cancer].
Zhang H; Zhang S; Zhang Z; Jia H; Gu S; Zhao D
Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):311-6. PubMed ID: 20677556
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of RASSF1A promoter hypermethylation in serum DNA of non-small cell lung cancer].
Yu ZH; Wang YC; Chen LB; Song Y; Liu C; Xia XY; Lin Q; Ma CY
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):284-7. PubMed ID: 18788633
[TBL] [Abstract][Full Text] [Related]
16. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer.
Ito M; Ito G; Kondo M; Uchiyama M; Fukui T; Mori S; Yoshioka H; Ueda Y; Shimokata K; Sekido Y
Cancer Lett; 2005 Jul; 225(1):131-9. PubMed ID: 15922865
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic inactivation of the thyroid hormone receptor beta1 gene at 3p24.2 in lung cancer.
Iwasaki Y; Sunaga N; Tomizawa Y; Imai H; Iijima H; Yanagitani N; Horiguchi K; Yamada M; Mori M
Ann Surg Oncol; 2010 Aug; 17(8):2222-8. PubMed ID: 20155399
[TBL] [Abstract][Full Text] [Related]
18. Development of a multiplex methylation specific PCR suitable for (early) detection of non-small cell lung cancer.
Nawaz I; Qiu X; Wu H; Li Y; Fan Y; Hu LF; Zhou Q; Ernberg I
Epigenetics; 2014 Aug; 9(8):1138-48. PubMed ID: 24937636
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer.
Mao WM; Li P; Zheng QQ; Wang CC; Ge MH; Hu FJ; Fang XH; Dong ZM; Ling ZQ
Arch Med Res; 2011 Apr; 42(3):182-8. PubMed ID: 21722812
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity and methylation of multiple tumor suppressor genes on chromosome 3 in hepatocellular carcinoma.
Zhang X; Li HM; Liu Z; Zhou G; Zhang Q; Zhang T; Zhang J; Zhang C
J Gastroenterol; 2013 Jan; 48(1):132-43. PubMed ID: 22766745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]